BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8443757)

  • 1. In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2.
    Lissoni P; Pittalis S; Brivio F; Tisi E; Rovelli F; Ardizzoia A; Barni S; Tancini G; Giudici G; Biondi A
    Cancer; 1993 Mar; 71(6):2076-81. PubMed ID: 8443757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2.
    Lissoni P; Tisi E; Brivio F; Barni S; Rovelli F; Perego M; Tancini G
    Eur J Cancer; 1991; 27(8):1014-6. PubMed ID: 1832885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of interleukin-2-induced macrophage activation in cancer patients by the pineal hormone melatonin.
    Lissoni P; Tisi E; Brivio F; Ardizzoia A; Crispino S; Barni S; Tancini G; Conti A; Maestroni GJ
    J Biol Regul Homeost Agents; 1991; 5(4):154-6. PubMed ID: 1803863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of macrophage response to interleukin-2 immunotherapy by interleukin-3 in cancer patients.
    Lissoni P; Rovelli F; Barni S; Ardizzoia A; Pittalis S; Tisi E; Perlangeli V; Tancini G
    Biol Chem Hoppe Seyler; 1992 Dec; 373(12):1217-22. PubMed ID: 1292506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.
    Hofmann B; Bass H; Nishanian P; Faisal M; Figlin RA; Sarna GP; Fahey JL
    Clin Exp Immunol; 1992 Jun; 88(3):548-54. PubMed ID: 1606739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo biological results of the association between interleukin-2 and interleukin-3 in the immunotherapy of cancer.
    Lissoni P; Barni S; Tisi E; Rovelli F; Pittalis S; Rescaldani R; Vigoré L; Biondi A; Ardizzoia A; Tancini G
    Eur J Cancer; 1993; 29A(8):1127-32. PubMed ID: 8390845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patients.
    Crispino S; Lissoni P; Ardizzoia A; Rovelli F; Perego MS; Grassi MG; Barni S; Pittalis S; Tancini G
    J Biol Regul Homeost Agents; 1993; 7(3):92-4. PubMed ID: 8135145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin as a new possible anti-inflammatory agent.
    Lissoni P; Rovelli F; Meregalli S; Fumagalli L; Musco F; Brivio F; Brivio O; Esposti G
    J Biol Regul Homeost Agents; 1997; 11(4):157-9. PubMed ID: 9582617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2, melatonin and interleukin-12 as a possible neuroimmune combination in the biotherapy of cancer.
    Lissoni P; Pittalis S; Rovelli F; Vigorè L; Roselli MG; Brivio F
    J Biol Regul Homeost Agents; 1995; 9(2):63-6. PubMed ID: 9127635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptors.
    Lissoni P; Brivio F; Fumagalli L; Galimberti C; Cataldo M; Marsili MT; Brivio O; Barni S; Tancini G; Angelini A
    J Biol Regul Homeost Agents; 1994; 8(1):32-5. PubMed ID: 7976492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the mechanisms involved in the immunostimulatory action of the pineal hormone in cancer patients.
    Lissoni P; Barni S; Tancini G; Rovelli F; Ardizzoia A; Conti A; Maestroni GJ
    Oncology; 1993; 50(6):399-402. PubMed ID: 8233281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory effects of recombinant interleukin-3 treatment on human alveolar macrophages and monocytes.
    Thomassen MJ; Antal JM; Connors MJ; McLain D; Sandstrom K; Meeker DP; Budd GT; Levitt D; Bukowski RM
    J Immunother Emphasis Tumor Immunol; 1993 Jul; 14(1):43-50. PubMed ID: 8399069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy.
    Grimm EA; Smid CM; Lee JJ; Tseng CH; Eton O; Buzaid AC
    Clin Cancer Res; 2000 Oct; 6(10):3895-903. PubMed ID: 11051235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of cytokine production from TH2-lymphocytes and monocytes by the pineal neurohormone melatonin.
    Lissoni P; Pittalis S; Rovelli F; Roselli M; Ardizzoia A
    Oncol Rep; 1996 May; 3(3):541-3. PubMed ID: 21594408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effects of IL-12 in relation to the pineal endocrine function in metastatic cancer patients.
    Lissoni P; Rovelli F; Giani L; Fumagalli L; Mandalà M
    Nat Immun; 1998; 16(5-6):178-84. PubMed ID: 11061586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma.
    Lissoni P; Barni S; Tancini G; Ardizzoia A; Ricci G; Aldeghi R; Brivio F; Tisi E; Rovelli F; Rescaldani R
    Br J Cancer; 1994 Jan; 69(1):196-9. PubMed ID: 8286206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer.
    Lissoni P; Tisi E; Barni S; Ardizzoia A; Rovelli F; Rescaldani R; Ballabio D; Benenti C; Angeli M; Tancini G
    Br J Cancer; 1992 Jul; 66(1):155-8. PubMed ID: 1322155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high-dose interleukin 2 bolus treatment.
    Boccoli G; Masciulli R; Ruggeri EM; Carlini P; Giannella G; Montesoro E; Mastroberardino G; Isacchi G; Testa U; Calabresi F
    Cancer Res; 1990 Sep; 50(18):5795-800. PubMed ID: 2118421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of eosinophilia by melatonin during the immunotherapy of cancer with interleukin-2.
    Lissoni P; Ardizzoia A; Tisi E; Rossini F; Barni S; Tancini G; Conti A; Maestroni GJ
    J Biol Regul Homeost Agents; 1993; 7(1):34-6. PubMed ID: 8346714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting effects of interferon-gamma and interleukin-4 on neopterin generation from human adherent monocytes.
    Moutabarrik A; Takahara S; Namiki M; Kameoka H; Seguchi T; Yokokawa K; Takano Y; Sonoda T; Ishibashi M; Zaid D
    Lymphokine Cytokine Res; 1992 Dec; 11(6):327-30. PubMed ID: 1477185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.